SCHEMBL6788134

SCHEMBL6788134

COc1cc(-c2ccc(N)cc2C(=O)N2CCCN(C(=O)c3cc(N)ccc3-c3cc(OC)c(OC)c(OC)c3)CC2)cc(OC)c1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.51
HTT P42858 1/20 0.50
ALDH1A1 P00352 2/20 0.47
CYP1A2 P05177 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
PDE1A P54750 3/20 0.46
PDE1B Q01064 3/20 0.46
PDE1C Q14123 3/20 0.46
PDE3B Q13370 1/20 0.46
PDE3A Q14432 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
POLB P06746 1/20 0.45
HSD11B1 P28845 1/20 0.44
GAA P10253 2/20 0.44
CPS1 P31327 1/20 0.43
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43
ALOX15 P16050 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5573082 0.88 LMNA (0.47) ALDH1A1CYP1A2PDE1APDE1BPDE1C
Hydrochloric Acid SCHEMBL5570671 0.87 LMNA (0.46) ALDH1A1CYP1A2PDE1APDE1BPDE1C
SCHEMBL6792388 0.82 ALDH1A1 (0.52) RAB9AHTTALDH1A1CYP1A2MEN1
SCHEMBL6792818 0.77 ALDH1A1 (0.59) HTTALDH1A1CYP1A2L3MBTL1POLB
SCHEMBL7154189 0.75 MEN1 (0.65) HTTALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL6785283 0.75 ALDH1A1 (0.56) HTTALDH1A1CYP1A2L3MBTL1POLB
SCHEMBL6785344 0.75 ALDH1A1 (0.67) HTTALDH1A1CYP1A2L3MBTL1MEN1
SCHEMBL4640456 0.74 FYN (0.47) HTTMEN1KMT2APOLBKDM4E
SCHEMBL10156660 0.74 HPGD (0.67) HTTALDH1A1MEN1KMT2APOLB
SCHEMBL6787352 0.74 ALDH1A1 (0.55) HTTALDH1A1CYP1A2L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6828316-B2 Antiallergens KOWA CO., LTD. (JP) 2004-12-07 US disclosed
US-20020042414-A1 Diamide compound and medicine containing the same KOWA CO., LTD. (JP) 2002-04-11 US disclosed
US-6340682-B1 FOR THERAPY OF ALLERGIC IMMUNOLOGICAL DISEASE IS SELECTED FROM ASTHMA, ALLERGIC RHINITIS, INFLAMMATORY LARGE BOWEL DISEASE OR CONTACT DERMATITIS KOWA CO., LTD. (JP) 2002-01-22 US disclosed
EP-0926138-A1 DIAMIDE COMPOUNDS AND DRUGS CONTAINING THE SAME KOWA CO. LTD. (JP) 1999-06-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020042414-A1 Diamide compound and medicine containing the same HRH4, HRH2, HRH1 RAB9A 4494/4885HTT 2457/4885ALDH1A1 836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.